Valuation : Yield10 Bioscience, Inc.

Market Cap 229K 197K 185K 169K 318K 21.8M 320K 2.2M 854K 11.06M 860K 842K 36.61M P/E 2022
-0.6x
P/E 2023 -0.13x
Enterprise Value 2.34M 2.01M 1.89M 1.73M 3.24M 223M 3.27M 22.41M 8.72M 113M 8.78M 8.59M 374M EV / Sales 2022
14.6x
EV / Sales 2023 83x
Free-Float
86%
Yield 2022 *
-
Yield 2023 -
Current month+9,900.00%
1 month+9,900.00%
Current year+9,900.00%
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
17.26
5 years 0
Extreme 1.0E-6
210.24
10 years 0
Extreme 1.0E-6
8,927.99
Manager TitleAgeSince
Chief Executive Officer 68 2016-10-16
Director of Finance/CFO 70 2014-11-02
Director TitleAgeSince
Director/Board Member 68 2009-07-06
Chairman 69 2011-11-07
Director/Board Member 63 2017-03-01
Date Insider Type Main position Quantity % Market Cap. Importance
8/15/24 Tax

Chief Technology Officer

877 0.1365%
8/15/24 Tax

Chief Financial Officer

731 0.1138%
8/15/24 Tax

Investor Relations Manager

731 0.1138%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-100.00% 73
-1.23%-1.91%+0.98%+17.94% 50.47B
-1.11%-2.84%+420.04%+505.15% 44.56B
-0.21%+0.37%+36.88%+17.32% 43.08B
-1.95%-3.33%+8.29%+73.25% 41.7B
-0.94%-1.77%+18.34%+46.84% 33.21B
-1.11%-4.20%+25.49%+119.78% 16.77B
+6.10%+4.40% - - 16.28B
+0.25%-0.98%+11.91%+27.62% 14.58B
-1.12%-3.46%+76.50%+39.37% 13.92B
Average -0.13%-1.61%+66.49%+83.03% 27.46B
Weighted average by Cap. -0.60%-1.57%+88.95%+122.85%

Financials

2022 2023
Net sales 450K 387K 364K 332K 624K 42.82M 628K 4.31M 1.68M 21.71M 1.69M 1.65M 71.89M 60K 51.66K 48.51K 44.28K 83.18K 5.71M 83.78K 575K 224K 2.89M 225K 220K 9.59M
Net income -13.57M -11.68M -10.97M -10.01M -18.81M -1.29B -18.94M -130M -50.56M -655M -50.94M -49.83M -2.17B -14.46M -12.45M -11.69M -10.67M -20.04M -1.38B -20.18M -138M -53.88M -697M -54.27M -53.09M -2.31B
Net Debt -1.7M -1.46M -1.37M -1.25M -2.35M -161M -2.37M -16.26M -6.33M -81.88M -6.37M -6.23M -271M 2.11M 1.82M 1.71M 1.56M 2.93M 201M 2.95M 20.21M 7.86M 102M 7.92M 7.75M 337M
Logo Yield10 Bioscience, Inc.
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The Company is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).
Employees
29
Date Price Change Volume

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. YTENQ Stock